96968 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-10
HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#2ENGINEERED IMMUNOCYTOKINES, FUSION POLYPEPTIDES, AND IL10 POLYPEPTIDES
#3FUSION PROTEIN COMPRISING IL13
#4IL-10 VARIANT MOLECULES AND METHODS FOR TREATING INFLAMMATORY DISEASE AND ONCOLOGY
#5METHODS FOR REPROGRAMMING AND GENE EDITING CELLS
#6THERAPEUTIC MACROPHAGES
#7HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#8PEPTIDES WITH CYTOKINE-RELEASING ACTIVITY AND METHODS FOR CHARACTERIZING CYTOKINE-RELEASING PROFILES OF PEPTIDES
#9REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION
#10HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#11MEMBRANE-ANCHORED CYTOKINES, ENGINEERED IMMUNE CELLS, AND USES THEREOF
#12HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#13HETERODIMERIC FUSION PROTEIN AND USE THEREOF
#14Treatment of osteoarthritis and/or rheumatoid arthritis with pro-chondrogenic and/or chondrocyte protective factors
#15COMBINATION OF MACROPHAGE-DIRECTED IMMUNOTHERAPY AND CYTOKINES FOR TREATMENT OF CANCER
#16CHIMERIC MEMBRANE-BOUND CYTOKINES INCORPORATING COSTIMULATORY ELEMENTS FOR ENHANCING ANTI-INFLAMMATORY FUNCTION
#17COMPOSITIONS, FORMULATIONS AND INTERLEUKIN PRODUCTION AND PURIFICATION
#18BIFUNCTIONAL IL-2 AND IL-10 FUSION PROTEINS AND USES THEREOF
#19Treatment of osteoarthritis and/or rheumatoid arthritis with pro-chondrogenic and/or chondrocyte protective factors
#20COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS
#21IL10 AGONISTS AND METHODS OF USE THEREOF
#22DUAL CSF1-IL-10 CYTOKINE
#23TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS
#24COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT
#25CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#26CHIMERIC ANTIGEN RECEPTOR MODIFIED REGULATORY T CELLS FOR TREATING CANCER
#27HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#28POLY-DONOR CD4+ T CELLS EXPRESSING IL-10 AND USES THEREOF
#29TGF-Beta Polypeptides
#30ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents
#31CD4+ T CELLS EXPRESSING IL-10 AND CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#32POLYDONOR CD4+ T CELLS EXPRESSING IL-10 AND USES THEREOF
#33ADENOVIRAL EXPRESSION VECTOR AND METHODS AND CELL LINES FOR PRODUCTION
#34DUAL CYTOKINE FUSION PROTEINS COMPRISING IL-10
#35CD4+ T CELLS EXPRESSING IL-10 AND CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#36VECTOR CONSTRUCTS FOR DELIVERY OF NUCLEIC ACIDS ENCODING THERAPEUTIC ANTI-IGF-1R ANTIBODIES AND METHODS OF USING THE SAME
#37DOSING REGIMEN FOR IL-10 ENCODING EXPRESSION CONSTRUCT
#38IL10 VARIANTS AND USES THEREOF
#39IL-10 Monomer Fusion Protein and Use thereof
#40METHOD OF REDUCING BISPECIFIC T CELL ENGAGER OR CHIMERIC ANTIGEN RECEPTOR T CELL MEDIATED CYTOKINE RELEASE SYNDROME USING INTERLEUKINS-4, -10, OR A FUSION PROTEIN THEREOF
#41CELLULAR POPULATIONS AND USES THEREOF
#42Linker Polypeptides
#43INTERLEUKIN-10 MUTEINS AND FUSION PROTEINS THEREOF
#44IMMUNOMODULATORY MOLECULES AND USES THEREOF
#45IMMUNOMODULATING TRANSGENIC PLANTS AND RELATED METHODS
#46TREATMENT OF FIBROSIS
#47METHODS AND COMPOSITIONS TO ENHANCE THE ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN 10
#48ANTIBODIES COMPRISING A POLYPEPTIDE INSERTED IN FRAMEWORK 3 REGION
#49SYNTHETIC IMMUNO-SUPPRESSIVE CELLS AND METHODS OF USE THEREOF
#50METHOD OF TREATING DISEASES WITH ANTI-PD-L1/IL-10 FUSION PROTEINS
#51MODIFIED ORGANS AND TISSUES
#52ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF
#53COMPOSITIONS AND METHODS RELATED TO THE TREATMENT OF OCULAR DISEASES IN EQUINES
#54Generation and Utility of B Cell Subsets for Treatment of Chronic Obstructive Pulmonary Disease
#55SELF-POLARIZING IMMUNE CELLS
#56IL-10 VARIANT MOLECULES AND METHODS FOR TREATING INFLAMMATORY DISEASE AND ONCOLOGY
#57GENETICALLY-MODIFIED SACCHAROMYCES YEAST STRAINS AS PREVENTATIVE AND THERAPEUTIC AGENTS
#58ATP-dependent agonists of immune cells function as anticancer agents
#59APPLICATION OF GENETICALLY MODIFIED OLIGODENDROCYTE PROGENITOR CELLS IN MULTIPLE SCLEROSIS
#60COMPOSITIONS, FORMULATIONS AND INTERLEUKIN PRODUCTION AND PURIFICATION
#61IMMUNOTHERAPY FOR INFLAMMATORY BOWEL DISEASE AND/OR CANCER
#62ANTIBODIES TARGETING BAFF-R AND USE THEREOF
#63CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#64CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#65IMMUNOMODULATING TRANSGENIC PLANTS AND RELATED METHODS
#66ENGINEERED INTERLEUKIN-10 AND FUSION PROTEINS THEREOF
#67ANTI-NKP30 ANTIBODY AND APPLICATION THEREOF
#68CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#69COMPOSITIONS AND METHODS OF USE OF INTERLEUKIN-10 IN COMBINATION WITH IMMUNE CHECK-POINT PATHWAY INHIBITORS
#70SECRETABLE PAYLOAD REGULATION
#71Dual cytokine fusion proteins comprising IL-10
#72Dual cytokine fusion proteins comprising IL-10
#73Dual cytokine fusion proteins comprising IL-10
#74Dual cytokine fusion proteins comprising IL-10
#75Dual cytokine fusion proteins comprising IL-10
#76Chimeric Molecules Comprising an IL-10 or TGF-Beta Agonist Polypeptide
#77REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION
#78Dual cytokine fusion proteins comprising IL-10
#79Dual cytokine fusion proteins comprising IL-10
#80Dual cytokine fusion proteins comprising IL-10
#81Dual cytokine fusion proteins comprising IL-10
#82Dual cytokine fusion proteins comprising IL-10
#83HUMAN IL-10 RECEPTOR ALPHA FUSION PROTEINS
#84Fusion protein containing human interleukin-10 and Fc fragment and medical use thereof
#85TARGETED CYTOKINE CONSTRUCT FOR ENGINEERED CELL THERAPY
#86IMMUNOCYTOKINE FOR ACTIVATING HUMAN IL-10RA RECEPTOR AND USE THEREOF
#87FUSIONS OF MUTANT INTERLEUKIN-10 POLYPEPTIDES WITH ANTIGEN BINDING MOLECULES FOR MODULATING IMMUNE CELL FUNCTION
#88TGF-Beta Polypeptides
#89MESENCHYMAL STEM CELLS CO-EXPRESSING CXCR4 AND IL-10 AND USES THEREOF
#90Hypoimmunogenic Cells and Methods and Compositions for Their Production
#91BISPECIFIC RECOMBINANT PROTEIN AND USE THEREOF
#92Genetically Modified Bacteria Stably Expressing IL-10 and Insulin
#93METHOD OF REDUCING BISPECIFIC T CELL ENGAGER OR CHIMERIC ANTIGEN RECEPTOR T CELL MEDIATED CYTOKINE RELEASE SYNDROME USING INTERLEUKINS-4, -10, OR A FUSION PROTEIN THEREOF
#94SYSTEMS AND METHODS FOR ENHANCED IMMUNOTHERAPIES
#95CELLULAR POPULATIONS AND USES THEREOF
#96POLY-DONOR CD4+ T CELLS EXPRESSING IL-10 AND USES THEREOF
#97ENHANCED-AFFINITY ANTI-ECM NANOBODY-CYTOKINE FUSIONS AND THEIR APPLICATIONS
#98IMMUNOCYTOKINES FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY CONDITIONS
#99IL10 agonists and methods of use thereof
#100IL-10 MUTEINS AND FUSION PROTEINS THEREOF
#101ARTIFICIAL SECRETION PEPTIDES FOR HETEROLOGOUS PROTEIN PRODUCTION
#102COLLAGEN-TARGETED FUSION PROTEINS AND ANTIBODIES
#103METHODS AND COMPOSITIONS FOR CANCER TREATMENT
#104STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR
#105Compositions for Treatment of Vascular Disease
#106IL-10 MUTEINS
#107ENGINEERED INTERLEUKIN-10 POLYPEPTIDES AND USES THEREOF
#108METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASE
#109IL-10 AND USES THEREOF
#110Dual cytokine fusion proteins comprising IL-10
#111Dual cytokine fusion proteins comprising IL-10
#112GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
#113TGF-β polypeptides
#114CHIMERIC ANTIGEN RECEPTOR ANTI-INFLAMMATORY CELLS AND METHODS OF USE
#115Dual cytokine fusion proteins comprising IL-10
#116METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASE
#117ANTIBODY-INTERLEUKIN FUSION PROTEIN AND METHODS OF USE
#118Immunomodulating transgenic plants and related methods
#119Dual cytokine fusion proteins comprising IL-10
#120Dual cytokine fusion proteins comprising IL-10
#121Dual cytokine fusion proteins comprising IL-10
#122Dual cytokine fusion proteins comprising IL-10
#123NOVEL IL-10 VARIANT PROTEIN AND USE THEREOF
#124NOVEL FUSION PROTEIN AND USE OF SAME
#125PROTEINACEOUS HETERODIMER AND USE THEREOF
#126CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#127FUSION PROTEIN COMPRISING IL13
#128Compositions for treatment of vascular disease
#129Synthetic Peptides With Affinity for the Interleukin-10 Receptor, Pharmaceutical Composition and Use Thereof as Immunomodulators for Treating Autoimmune, Inflammatory or Allergic Diseases
#130GENETICALLY REPROGRAMMED TREGS EXPRESSING CARS
#131METHODS AND COMPOSITIONS FOR IL10 SIGNALING ANTAGONISM
#132ANTIBODY CYTOKINE ENGRAFTED COMPOSITIONS AND METHODS OF USE FOR IMMUNOREGULATION
#133Compositions, formulations and interleukin production and purification
#134IL-10 VARIANT MOLECULES AND METHODS FOR TREATING INFLAMMATORY DISEASE AND ONCOLOGY
#135Compositions, formulations and interleukin production and purification
#136Antibodies comprising a polypeptide inserted in framework 3 region
#137Methods and reagents for modulating macrophage phenotype
#138Dual cytokine fusion proteins comprising IL-10
#139INTERLEUKIN-10 POLYPEPTIDE CONJUGATES, DIMERS THEREOF, AND THEIR USES
#140IL-10-CONTAINING VACCINES AND USES THEREOF
#141IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODUCTION AND USE THEREOF FOR TREATMENT OF CANCER
#142IL10 agonists and methods of use thereof
#143GENETICALLY REPROGRAMMED TREGS EXPRESSING MEMBRANE-BOUND IL-10
#144COMPOSITIONS AND METHODS OF USE OF IL-10 AGENTS IN CONJUNCTION WITH CHIMERIC ANTIGEN RECEPTOR CELL THERAPY
#145INTERLEUKIN 10 CONJUGATES AND USES THEREOF
#146NSP-INTERLEUKIN-10 PROTEINS AND USES THEREOF
#147Compositions for treatment of vascular disease
#148Adenoviral expression vector and methods and cell lines for production
#149THERAPEUTIC INDUCTION OF TOLERANCE USING RECOMBINANT CELL SURFACE ANTIGENS
#150Mammalian alveolar macrophages derived from pluripotent cells
#151Methods and compositions for treating autoimmune and inflammatory conditions
#152HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#153Salt-tolerant , method of culturing salt-tolerant , and immunostimulant
#154COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT
#155Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#156METHOD OF USING GENETIC MARKERS, SINGLE NUCLEOTIDE POLYMORPHISMS AND/OR INDELS TO DETERMINE RESPONSIVENESS TO IL-10 OR IL-10 DERIVATIVE TREATMENT
#157Fusion protein comprising IL13
#158CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#159Treatment of fibrosis
#160Genetically modified bacteria stably expressing IL-10 and insulin
#161SINGLE CHAIN Fc FUSION PROTEINS
#162Compositions, formulations and interleukin production and purification
#163Untargeted and targeted IL-10 Fc-fusion proteins
#164Compositions, formulations and interleukin production and purification
#165RECOMBINANT CANCER THERAPEUTIC CYTOKINE
#166Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist
#167GENETICALLY REPROGRAMMED TREGS EXPRESSING MEMBRANE-BOUND IL-10
#168IL-10 VARIANT MOLECULES AND METHODS FOR TREATING INFLAMMATORY DISEASE AND ONCOLOGY
#169CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
#170IL-10 variant molecules conjugated with antibody variable domain regions
#171IL-10 variant molecules and methods of treating inflammatory disease
#172Antibody-IL-10 fusion proteins
#173Methods for treating malignant tumors with IL-10 variant conjugates
#174METHOD OF TREATING A METABOLIC DISORDER OF THE LIVER
#175Tolerogenic DNA vaccine
#176Expression of metabolic modulators in tumor microenvironment to improve tumor therapy
#177Antibody variable domain regions fused to IL-10 variant molecules
#178Proteinaceous heterodimer and use thereof
#179Artificial secretion peptides for heterologous protein production
#180NOVEL INTERLEUKIN 4 IMMUNOCONJUGATES
#181Human IL-10 receptor alpha fusion proteins
#182STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR
#183Nsp-interleukin-10 proteins and uses thereof
#184Cellular populations and uses thereof
#185Fusion protein comprising IL-4 and IL-10
#186METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASE
#187Immunomodulating transgenic plants and related methods
#188IL-10 EGFR antibody fusion protein and uses thereof
#189Activatable antibodies and methods of use thereof
#190Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#191METHOD FOR THE PREPARATION AND PROLONGED STORAGE OF GROWTH FACTORS AND CYTOKINES OBTAINED FROM PLATELET RICH PLASMA
#192Compositions and methods for modulating IL-10 immunostimulatory and anti-inflammatory properties
#193METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#194METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#195Genetically modified bacteria stably expressing IL-10 and insulin
#196Methods and reagents for modulating macrophage phenotype
#197CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF
#198ARTIFICIAL ANTIGEN PRESENTING CELLS FOR EXPANDING IMMUNE CELLS FOR IMMUNOTHERAPY
#199Methods of treating immune related disorders using antibody-cytokine engrafted compositions
#200Regulated biocircuit systems
#201Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Production and Use Thereof for Treatment of Cancer
#202GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR WOUND HEALING
#203Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#204Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#205Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#206METHODS AND COMPOSITIONS TO ENHANCE THE ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN 10
#207Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#208Skin probiotic formulation
#209THERAPEUTIC INDUCTION OF TOLERANCE USING RECOMBINANT CELL SURFACE ANTIGENS
#210METHODS OF PRODUCING AND PURIFYING MATRIX-BINDING FUSION PROTEINS BY ION-EXCHANGE CHROMATOGRAPHY
#211Treatment of fibrosis with interleukin-11 antibody
#212Treatment of fibrosis with interleukin-11 receptor alpha antibody
#213Treatment of fibrosis with interleukin-11 receptor alpha antibody
#214Treatment of fibrosis with interleukin-11 antibody
#215Treatment of fibrosis with interleukin-11 receptor alpha antibody
#216Treatment of fibrosis with IL-11 receptor alpha antibody
#217Treatment of fibrosis with Interleukin-11 receptor alpha antibody
#218Treatment of fibrosis with interleukin-11 receptor alpha antibody
#219Treatment of fibrosis with interleukin-11 antibody
#220Treatment of fibrosis with interleukin-11 antibody
#221Treatment of fibrosis with interleukin-11 antibody
#222Treatment of fibrosis with interleukin-11 antibody
#223Vectors Conditionally Expressing Protein
#224RECOMBINANT CANCER THERAPEUTIC CYTOKINE
#225Single chain Fc fusion proteins
#226Chimeric antigen receptor anti-inflammatory cells and methods of use
#227Methods of using interleukin-10 for treating solid tumors
#228Pegylated interleukin-10
#229Tumor infiltrating lymphocytes for treatment of cancer
#230Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
#231Methods of treatment with a fusion protein comprising IL-4 and IL-10
#232T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THEREOF
#233A SOLUBLE CHIMERIC INTERLEUKIN-10 RECEPTOR AND THERAPEUTIC USE THEREOF
#234Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11
#235Compositions for modulating IL-10 immunostimulatory and anti-inflammatory properties
#236Methods of Improving Yield in Recombinant Protein Production
#237PROBIOTIC ORGANISMS FOR DIAGNOSIS, MONITORING, AND TREATMENT OF INFLAMMATORY BOWEL DISEASE
#238Proteinaceous heterodimer and use thereof
#239Cytokine-based fusion proteins for treatment of immune disorders
#240Antibody cytokine engrafted compositions and methods of use for immunoregulation
#241Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#242ENGINEERED BACTEROIDES OUTER MEMBRANE VESICLES
#243Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
#244Methods and compositions for treating autoimmune and inflammatory conditions
#245Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection
#246Interleukin-10 fusion proteins and uses thereof
#247Methods for the treatment of inflammatory joint disease
#248SINGLE CHAIN FC FUSION PROTEINS
#249Pegylated interleukin-10
#250Recombinant cancer therapeutic cytokine
#251STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR
#252Interleukin-10 Compositions and Uses Thereof
#253Methods of using pegylated interleukin-10 for treating cancer
#254HUMANIZED TRANSGENIC SINGLE NUCLEOTIDE POLYMORPHISM ANIMAL SYSTEMS
#255INTERLEUKIN-10 FUSION PROTEINS AND USES THEREOF
#256Cytokine-based fusion proteins for treatment of immune disorders
#257Methods of producing and using regulatory B-cells
#258Interleukin-10 Polypeptide Conjugates and Their Uses
#259FUSION PROTEIN COMPRISING AN INTERLEUKIN 4 AND INTERLEUKIN
#260Vectors conditionally expressing protein
#261Pegylated interleukin-10
#262DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#263Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection
#264Interleukin-10 fusion proteins
#265Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection
#266Gelsolin stimulation of blood samples using gold particles
#267COVALENTLY LINKED INTERLEUKIN-10
#268Use of interleukin 10 mRNA transfected macrophages in anti-inflammatory therapies
#269Immunomodulatory methods and systems for treatment and/or prevention of hypertension
#270Heterodimeric human IgG1 polypeptides with isoelectric point modifications
#271T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THEREOF
#272PEPTIDES WITH THE CAPACITY TO BIND TO INTERLEUKIN-10 (IL-10)
#273Method of treatment of gastrointestinal disorders with IL-10
#274Peptides for active anti-cytokine immunization
#275LATENT PHASE VIRAL INTERLEUKIN-10-(VII-10) AND USES THEREOF
#276Peptides for active anti-cytokine immunization
#277CD86 antagonist multi-target binding proteins
#278Pegylated interleukin-10
#279COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISORDERS
#280Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritis
#281Cysteine variants of interferon gamma
#282Peptides for active anti-cytokine immunization
#283Pegylated Interleukin-10
#284PEGYLATED INTERLEUKIN-10
#285Composition and Method for Treating Inflammatory Disorders
#286Peptides with capacity for binding with interleukine 10 (IL-10)
#287Peptides for active anti-cytokine immunization
#288Lactococcus promoters and uses thereof
#289Cytokine-based fusion proteins for treatment of multiple sclerosis
#290Reduction of Ophthalmalogic Neovascularization
#291Therapeutic Agent For Alzheimer's Disease
#292Human GIL-19/AE289 proteins
#293Latent phase viral interleukin-10-(VII-10) and uses thereof
#294DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#295Mutant IL-10
#296Cysteine variants of interferon gamma
#297PEGYLATED INTERLEUKIN-10
#298Peptides for active anti-cytokine immunization
#299COMPOSITIONS AND METHODS FOR PRIMING MONOCYTIC DENDRITIC CELLS AND T CELLS FOR TH-1 RESPONSE
#300Use of Recombinant Yeast Strain Producing an Anti-Inflammatory Compound to Treat Colitis